Cancer Diagnostics Global Market Opportunities And Strategies To 2033

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $5,000	313 Pages	The Business Research Company	May, 2024	BRC18789881

Best Price Guarantee
Price	from $5,000
Length	313 Pages
Publisher	The Business Research Company
Published Date	May, 2024
SKU	BRC18789881

Cancer Diagnostics Global Market Opportunities And Strategies To 2033

Including: 1) By Method: Biopsy, Endoscopy; Tumor Biomarker Tests; Imaging2) By Application: Cervical Cancer; Breast Cancer; Lung Cancer; Brain and Central Nervous System Cancer; Kidney Cancer; Colorectal Cancer; Prostate Cancer; Ovarian Cancer; Stomach Cancer3) By End User: Cancer Research Institutes; Diagnostic Laboratories; HospitalsCovering: Thermo Fisher Scientific Inc.; F. Hoffmann-La Roche Ltd.; Abbott Laboratories Inc.; Illumina Inc.; Hologic Inc.

Cancer Diagnostics Global Market Opportunities And Strategies To 2033 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global cancer diagnostics market as it emerges from the COVID-19 shut down.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market research findings.
Benchmark performance against key competitors.
Utilize the relationships between key data sets for superior strategizing.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

Description:

Where is the largest and fastest-growing market for cancer diagnostics? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The cancer diagnostics market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market’s history and forecasts market growth by geography. It places the market within the context of the wider cancer diagnostics market; and compares it with other markets.

The report covers the following chapters

Introduction and Market Characteristics- Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by method, by application and by end-user.
Key Trends- Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
Macro-Economic Scenario- The report provides an analysis of the impact of the COVID-19 pandemic, impact of the Russia-Ukraine war and impact of rising inflation on global and regional markets, providing strategic insights for businesses in the cancer diagnostics market.
Global Market Size And Growth- Global historic (2018-2023) and forecast (2023-2028, 2033F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
Regional And Country Analysis- Historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison by region and country.
Market Segmentation- Contains the market values (2018-2023) (2023-2028, 2033F) and analysis for each segment by method, by application and by end-user in the market. Historic (2018-2023) and forecast (2023-2028) and (2028-2033) market values and growth and market share comparison by region market.
Regional Market Size and Growth- Regional market size (2023), historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
Competitive Landscape- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
Competitive Benchmarking- Briefs on the financials comparison between major players in the market.
Competitive Dashboard- Briefs on competitive dashboard of major players.
Key Mergers and Acquisitions- Information on recent mergers and acquisitions in the market is covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
Conclusions And Recommendations- This section includes recommendations for cancer diagnostics providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
Appendix- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Markets Covered:

1) By Method: Biopsy, Endoscopy; Tumor Biomarker Tests; Imaging; Other Methods

2) By Application: Cervical Cancer; Breast Cancer; Lung Cancer; Brain and Central Nervous System Cancer; Kidney Cancer; Colorectal Cancer; Prostate Cancer; Ovarian Cancer; Stomach Cancer; Other Applications

3) By End User: Cancer Research Institutes; Diagnostic Laboratories; Hospitals; Other End-Users

Companies Mentioned: Thermo Fisher Scientific Inc; F. Hoffmann-La Roche Ltd.; Abbott Laboratories Inc.; Illumina Inc.; Hologic Inc.

Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; Italy; Spain; UK; Russia

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time-series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; cancer diagnostics indicators comparison.

Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

1 Executive Summary: 1.1 Cancer Diagnostics – Market Attractiveness And Macro economic Landscape
2 Table Of Contents
3 List Of Tables
4 List Of Figures
5 Report Structure
6 Market Characteristics: 6.1 General Market Definition; 6.2 Summary; 6.3 Cancer Diagnostics Market Definition And Segmentations; 6.4 Market Segmentation By Method; 6.4.1 Biopsy; 6.4.2 Endoscopy; 6.4.3 Tumor Biomarker Tests; 6.4.4 Imaging; 6.4.5 Other Methods; 6.5 Market Segmentation By Application; 6.5.1 Cervical Cancer; 6.5.2 Breast Cancer; 6.5.3 Lung Cancer; 6.5.4 Brain And Central Nervous System Cancer; 6.5.5 Kidney Cancer; 6.5.6 Colorectal Cancer; 6.5.7 Prostate Cancer; 6.5.8 Ovarian Cancer; 6.5.9 Stomach Cancer; 6.5.10 Other Applications; 6.6 Market Segmentation By End-User; 6.6.1 Cancer Research Institutes; 6.6.2 Diagnostic Laboratories; 6.6.3 Hospitals; 6.6.4 Other End-Users
7 Cancer Diagnostics Market - Macro Economic Scenario: 7.1 COVID-19 Impact On The Cancer Diagnostics Market; 7.2 Impact Of The War In Ukraine On The Cancer Diagnostics Market; 7.3 Impact Of High Inflation On The Cancer Diagnostics Market
8 Major Market Trends: 8.1 Technological Advancements To Provide Automated Diagnostics Solutions; 8.2 Strategic Partnerships And Acquisitions To Drive Innovation In Cancer Diagnostics; 8.3 Developments In Blood-Borne Circulating Biomarkers For Cancer Detection; 8.4 Focus On AI-Based Tools In Cancer Diagnosis
9 Global Market Size and Growth: 9.1 Market Size; 9.2 Historic Market Growth, 2018 – 2023, Value ($ Million); 9.2.1 Market Drivers 2018 – 2023; 9.2.2 Market Restraints 2018 – 2023; 9.3 Forecast Market Growth, 2023 – 2028, 2033F Value ($ Million); 9.3.1 Market Drivers 2023 – 2028; 9.3.2 Market Restraints 2023 – 2028
10 Global Cancer Diagnostics Market Segmentation: 10.1 Global Cancer Diagnostics Market, Segmentation By Method, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 10.2 Global Cancer Diagnostics Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 10.3 Global Cancer Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
11 Cancer Diagnostics Market, Regional and Country Analysis: 11.1 Global Cancer Diagnostics Market, By Region, Historic and Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 11.2 Global Cancer Diagnostics Market, By Country, Historic and Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
12 Asia-Pacific Market: 12.1 Summary; 12.1.1 Market Overview; 12.1.2 Region Information; 12.1.3 Market Information; 12.1.2 62; 12.1.3 62; 12.1.4 62; 12.1.5 Background Information; 12.1.6 Government Initiatives; 12.1.6 Regulations; 12.1.7 Regulatory Bodies; 12.1.8 Major Associations; 12.1.9 Taxes Levied; 12.1.10 Corporate Tax Structure; 12.1.11 Investments; 12.1.12 Major Companies; 12.2 Asia-Pacific Cancer Diagnostics Market, Segmentation By Method, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 12.3 Asia-Pacific Cancer Diagnostics Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 12.4 Asia-Pacific Cancer Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 12.5 Asia-Pacific Cancer Diagnostics Market: Country Analysis; 12.6 China Market; 12.7 Summary; 12.7.1 Market Overview; 12.1.13 Country Information; 12.1.14 Market Information; 12.1.15 Background Information; 12.8 75; 12.9 75; 12.9.1 75; 12.9.2 75; 12.9.3 75; 12.9.4 Government Initiatives; 12.1.16 Regulations; 12.1.17 Regulatory Bodies; 12.1.18 Major Associations; 12.1.19 Taxes Levied; 12.1.20 Corporate Tax Structure; 12.1.21 Investments; 12.1.22 Major Companies; 12.1 China Cancer Diagnostics Market, Segmentation By Method, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 12.11 China Cancer Diagnostics Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 12.12 China Cancer Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 12.13 India Market; 12.14 India Cancer Diagnostics Market, Segmentation By Method, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 12.15 India Cancer Diagnostics Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 12.16 India Cancer Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 12.17 Japan Market; 12.18 Japan Cancer Diagnostics Market, Segmentation By Method, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 12.19 Japan Cancer Diagnostics Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 12.20 Japan Cancer Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 12.21 Australia Market; 12.22 Australia Cancer Diagnostics Market, Segmentation By Method, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 12.23 Australia Cancer Diagnostics Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 12.24 Australia Cancer Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 12.25 Indonesia Market; 12.26 Indonesia Cancer Diagnostics Market, Segmentation By Method, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 12.27 Indonesia Cancer Diagnostics Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 12.28 Indonesia Cancer Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 12.29 South Korea Market; 12.30 South Korea Cancer Diagnostics Market, Segmentation By Method, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 12.31 South Korea Cancer Diagnostics Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 12.32 South Korea Cancer Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
13 Western Europe Market: 13.1 Summary; 13.1.1 Market Overview; 13.1.2 Region Information; 13.1.3 Market Information; 13.1.4 Background Information; 13.1.5 Government Initiatives; 13.1.6 Regulations; 13.1.7 Regulatory Bodies; 13.1.8 Major Associations; 13.1.9 Taxes Levied; 13.1.10 Corporate Tax Structure; 13.1.11 Investments; 13.1.12 Major Companies; 13.2 Western Europe Cancer Diagnostics Market, Segmentation By Method, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 13.3 Western Europe Cancer Diagnostics Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 13.4 Western Europe Cancer Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 13.5 Western Europe Cancer Diagnostics Market: Country Analysis; 13.6 UK Market; 13.7 UK Cancer Diagnostics Market, Segmentation By Method, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 13.8 UK Cancer Diagnostics Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 13.9 UK Cancer Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 13.10 Germany Market; 13.11 Germany Cancer Diagnostics Market, Segmentation By Method, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 13.12 Germany Cancer Diagnostics Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 13.13 Germany Cancer Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 13.14 France Market; 13.15 France Cancer Diagnostics Market, Segmentation By Method, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 13.16 France Cancer Diagnostics Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 13.17 France Cancer Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 13.18 Italy Market; 13.19 Italy Cancer Diagnostics Market, Segmentation By Method, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 13.20 Italy Cancer Diagnostics Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 13.21 Italy Cancer Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 13.22 Spain Market; 13.23 Spain Cancer Diagnostics Market, Segmentation By Method, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 13.24 Spain Cancer Diagnostics Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 13.25 Spain Cancer Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
14 Eastern Europe Market: 14.1 Summary; 14.1.1 Market Overview; 14.1.2 Region Information; 14.1.3 Market Information; 14.1.4 Background Information; 14.1.5 Government Initiatives; 14.1.6 Regulations; 14.1.7 Regulatory Bodies; 14.1.8 Major Associations; 14.1.9 Taxes Levied; 14.1.10 Corporate Tax Structure; 14.1.11 Investments; 14.1.12 Major Companies; 14.2 Eastern Europe Cancer Diagnostics Market, Segmentation By Method, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 14.3 Eastern Europe Cancer Diagnostics Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 14.4 Eastern Europe Cancer Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 14.5 Eastern Europe Cancer Diagnostics Market: Country Analysis; 14.6 Russia Market; 14.7 Russia Cancer Diagnostics Market, Segmentation By Method, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 14.8 Russia Cancer Diagnostics Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 14.9 Russia Cancer Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
15 North America Market: 15.1 Summary; 15.1.1 Market Overview; 15.1.2 Region Information; 15.1.3 Market Information; 15.1.4 Background Information; 15.1.5 Government Initiatives; 15.1.6 Regulations; 15.1.7 Regulatory Bodies; 15.1.8 Major Associations; 15.1.9 Taxes Levied; 15.1.10 Corporate Tax Structure; 15.1.11 Investments; 15.1.12 Major Companies; 15.2 North America Cancer Diagnostics Market, Segmentation By Method, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 15.3 North America Cancer Diagnostics Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 15.4 North America Cancer Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 15.5 North America Cancer Diagnostics Market: Country Analysis; 15.6 USA Market; 15.7 Summary; 15.7.1 Market Overview; 15.7.2 Country Information; 15.7.3 Market Information; 15.7.4 Background Information; 15.7.5 Government Initiatives; 15.7.6 Regulations; 15.7.7 Regulatory Bodies; 15.7.8 Major Associations; 15.7.9 Taxes Levied; 15.7.10 Corporate Tax Structure; 15.7.11 Investments; 15.7.12 Major Companies; 15.8 USA Cancer Diagnostics Market, Segmentation By Method, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 15.9 USA Cancer Diagnostics Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 15.10 USA Cancer Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 15.11 Canada Market; 15.12 Canada Cancer Diagnostics Market, Segmentation By Method, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 15.13 Canada Cancer Diagnostics Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 15.14 Canada Cancer Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
16 South America Market: 16.1 Summary; 16.1.1 Market Overview; 16.1.2 Region Information; 16.1.3 Market Information; 16.1.4 Background Information; 16.1.5 Government Initiatives; 16.1.6 Regulations; 16.1.7 Regulatory Bodies; 16.1.8 Major Associations; 16.1.9 Taxes Levied; 16.1.10 Corporate Tax Structure; 16.1.11 Investments; 16.1.12 Major Companies; 16.2 South America Cancer Diagnostics Market, Segmentation By Method, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 16.3 South America Cancer Diagnostics Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 16.4 South America Cancer Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 16.5 South America Cancer Diagnostics Market: Country Analysis; 16.6 Brazil Market; 16.7 Brazil Cancer Diagnostics Market, Segmentation By Method, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 16.8 Brazil Cancer Diagnostics Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 16.9 Brazil Cancer Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
17 Middle East Market: 17.1 Summary; 17.1.1 Market Overview; 17.1.2 Region Information; 17.1.3 Market Information; 17.1.4 Background Information; 17.1.5 Government Initiatives; 17.1.6 Regulations; 17.1.7 Regulatory Bodies; 17.1.8 Major Associations; 17.1.9 Taxes Levied; 17.1.10 Corporate Tax Structure; 17.1.11 Investments; 17.1.12 Major Companies; 17.2 Middle East Cancer Diagnostics Market, Segmentation By Method, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 17.3 Middle East Cancer Diagnostics Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 17.4 Middle East Cancer Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
18 Africa Market: 18.1 Summary; 18.1.1 Market Overview; 18.1.2 Region Information; 18.1.3 Market Information; 18.1.4 Background Information; 18.1.5 Government Initiatives; 18.1.6 Regulations; 18.1.7 Regulatory Bodies; 18.1.8 Major Associations; 18.1.9 Taxes Levied; 18.1.10 Corporate Tax Structure; 18.1.11 Investments; 18.1.12 Major Companies; 18.2 Africa Cancer Diagnostics Market, Segmentation By Method, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 18.3 Africa Cancer Diagnostics Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 18.4 Africa Cancer Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
19 Competitive Landscape And Company Profiles: 19.1 Company Profiles; 19.2 Thermo Fisher Scientific Inc.; 19.2.1 Company Overview; 19.2.2 Products And Services; 19.2.3 Business Strategy; 19.2.4 Financial performance; 19.3 F. Hoffman-La Roche Ltd; 19.3.1 Company Overview; 19.3.2 Products And Services; 19.3.3 Business Strategy; 19.3.4 Financial Overview; 19.4 Abbott Laboratories; 19.4.1 Company Overview; 19.4.2 Products And Services; 19.4.3 Business Strategy; 19.4.4 Financial Overview; 19.5 Illumina Inc.; 19.5.1 Company Overview; 19.5.2 Products And Services; 19.5.3 Business Strategy; 19.5.4 Financial Overview; 19.6 Hologic Inc; 19.6.1 Company Overview; 19.6.2 Products And Services; 19.6.3 Business Strategy; 19.6.4 Financial Overview
20 Competitive Dashboard
21 Key Mergers And Acquisitions: 21.1 Quest Diagnostics Acquired Haystack Oncology Inc.; 21.2 Agilent Technologies Inc. Acquired Biomed Inc.; 21.3 Thermo Fisher Scientific Inc. Acquired The Binding Site Group; 21.4 Hologic Inc. Acquired Biotheranostics Inc.; 21.5 Illumina Inc. Acquired GRAIL
22 Opportunities And Strategies: 22.1 Global Cancer Diagnostics Market In 2028 – Countries Offering Most New Opportunities; 22.2 Global Cancer Diagnostics Market In 2028 – Segments Offering Most New Opportunities; 22.3 Global Cancer Diagnostics Market In 2028 – Growth Strategies; 22.3.1 Market Trend Based Strategies; 22.3.2 Competitor Strategies
23 Cancer Diagnostics Market, Conclusions And Recommendations: 23.1 Conclusions; 23.2 Recommendations; 23.2.1 Product; 23.2.2 Place; 23.2.3 Price; 23.2.4 Promotion; 23.2.5 People
24 Appendix: 24.1 Geographies Covered; 24.2 Market Data Sources; 24.3 Research Methodology; 24.4 Currencies; 24.5 The Business Research Company; 24.6 Copyright and Disclaimer